Urokinase Plasminogen Activator Receptor Attenuates Allergen-induced Eosinophil Migration and Airway Hyperresponsiveness
American Journal of Respiratory Cell and Molecular Biology · 2025
DOI: 10.1165/rcmb.2025-0308oc ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Respiratory Cell and Molecular Biology, 2025. Verfasst von Gregory S Whitehead und 10 weiteren Autor:innen. Beteiligte Einrichtung: Immunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Durham, NC, United…. Hauptthemen laut MEDLINE: Receptors, Urokinase Plasminogen Activator, Eosinophils, Allergens, Asthma. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, NIH HHS, NIEHS NIH HHS.
Abstract (Originalsprache)
Allergic asthma is a widespread disease of the airway stemming from the actions of multiple cell types, including eosinophils and epithelial cells. The urokinase plasminogen activator receptor (uPAR) is a membrane bound protein that can contribute to the activation and mobilization of leukocytes and is present at increased levels in asthmatics. However, its role in allergic asthma remains poorly understood. Here, we used multiple mouse strains and different models of allergic airway disease to study the function of uPAR in the pathogenesis of this disease. Plaur, the gene encoding uPAR, was rapidly induced following allergic sensitization through the airway, and again following subsequent allergen challenge. Plaur-deficient mice displayed both increased numbers of eosinophils and heightened airway hyperresponsiveness (AHR) in multiple models of allergic asthma. Mice selectively lacking Plaur in eosinophils also had more robust eosinophilia than did WT mice, and eosinophils lacking Plaur displayed increased activity in an ex vivo assay of chemokine-dependent migration. However, those mice did not have increased AHR compared with WT mice. Conversely, although mice selectively lacking Plaur in lung epithelial cells did not have increased inflammation compared with wild type (WT) mice, they displayed heightened AHR. These findings suggest that uPAR controls both airway inflammation and AHR, but through distinct mechanisms. Targeting uPAR might have therapeutic potential for treating inflammation and AHR in asthma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Durham, NC, United States.
- Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Durham, NC, United States.
- Gene Editing and Mouse Model Core Facility, National Institute of Environmental Health Sciences, National Institutes of Health, Durham, NC, United States.
ORCID-Profile: Artiom Gruzdev
Förderung
- Intramural NIH HHS
- NIH HHS
- NIEHS NIH HHS
Zitieren
APA
Whitehead, G. S., Nakano, K., Wilkinson, C. L., Patterson, A. M., Upadhyay, S., Massri, A. J., Papas, B. N., Gruzdev, A., Ray, M., Nakano, H., & Cook, D. N. (2025). Urokinase Plasminogen Activator Receptor Attenuates Allergen-induced Eosinophil Migration and Airway Hyperresponsiveness. American Journal of Respiratory Cell and Molecular Biology. https://doi.org/10.1165/rcmb.2025-0308oc
Vancouver
Whitehead GS, Nakano K, Wilkinson CL, Patterson AM, Upadhyay S, Massri AJ, et al. Urokinase Plasminogen Activator Receptor Attenuates Allergen-induced Eosinophil Migration and Airway Hyperresponsiveness. American Journal of Respiratory Cell and Molecular Biology. 2025. doi:10.1165/rcmb.2025-0308oc
BibTeX
@article{Whitehead2025,
author = {Whitehead, Gregory S and Nakano, Keiko and Wilkinson, Christina L and Patterson, Antonio M and Upadhyay, Sandeep and Massri, Abdull J and Papas, Brian N and Gruzdev, Artiom and Ray, Manas and Nakano, Hideki and Cook, Donald N},
title = {Urokinase Plasminogen Activator Receptor Attenuates Allergen-induced Eosinophil Migration and Airway Hyperresponsiveness},
journal = {American Journal of Respiratory Cell and Molecular Biology},
year = {2025},
doi = {10.1165/rcmb.2025-0308oc}
}
EUVIMED